Zobrazeno 1 - 10
of 38
pro vyhledávání: '"G. G. Karganova"'
Autor:
V. A. Lashkevich, G. G. Karganova
Publikováno v:
Вопросы вирусологии, Vol 63, Iss 3, Pp 101-105 (2018)
In Russia, about 2000 people get tick-borne encephalitis (TBE) every year. Almost none of them are vaccinated. For the prevention of TBE, inactivated vaccines (IVTBE) are used. IVTBE are safe and protect from TBE not less than 95% of vaccinated. The
Externí odkaz:
https://doaj.org/article/008b1aa11b8f457d951e4145da39aa0b
Autor:
L. L. Chernokhaeva, G. B. Maikova, Yu. V. Rogova, V. V. Romanenko, A. V. Ankudinova, A. S. Kilyachina, M. F. Vorovich, G. G. Karganova
Publikováno v:
Вопросы вирусологии, Vol 63, Iss 1, Pp 36-40 (2018)
The enzyme-linked immunosorbent assay (ELISA) and the neutralization test (NT) are often used to determine the level of seropositive population and to evaluate the immunogenicity of vaccines. ELISA provides information on the total pool of antiviral
Externí odkaz:
https://doaj.org/article/4ff7e6f9d30d46308e22de5dd524e025
Autor:
M. F. Vorovitch, G. B. Maikova, L. L. Chernokhaeva, V. V. Romanenko, A. V. Ankudinova, Yu. Kh. Khapchaev, G. G. Karganova, A. A. Ishmukhametov, S. G. Drozdov
Publikováno v:
Вопросы вирусологии, Vol 62, Iss 2, Pp 73-80 (2017)
About 3,000 cases of TBE are registered annually in the Russian Federation. Vaccination is the main way to prevent the tick-borne encephalitis disease. Comparative study of the reactogenicity and immunogenicity of a new vaccine «Tick-E-Vac» was hel
Externí odkaz:
https://doaj.org/article/4812a9f58e4a43c69489b49c65253e84
Autor:
A. A. Deviatkin, A. N. Lukashev, E. M. Poleshchuk, S. E. Tkachev, V. G. Dedkov, G. N. Sidorov, M. Yu. Shchelkanov, I. V. Galkina, G. G. Karganova, M. V. Gavrilo, G. A. Shipulin
Publikováno v:
Эпидемиология и вакцинопрофилактика, Vol 16, Iss 1, Pp 39-42 (2017)
In this study, we report the phylogenetic relationship of RABV circulating in Russia. A total of 81 new isolates obtained from different regions of Russia in 2008 - 2016 were partially sequenced. Evolutionary analysis based on 100 representative sequ
Externí odkaz:
https://doaj.org/article/9212f73e79cd4e62a3e5120d0a176ac2
Publikováno v:
Voprosy virusologii. 61(3)
Serum of children aged 1 to 16 obtained in the course of clinical trials conducted in the sverdlovsk region in 2011 was used to study the post-vaccination immunity. Children were immunized twice with vaccines against the tick-borne encephalitis (TBE)
Autor:
V A, Lashkevich, G G, Karganova
Publikováno v:
Voprosy virusologii. 63(3)
In Russia, about 2000 people get tick-borne encephalitis (TBE) every year. Almost none of them are vaccinated. For the prevention of TBE, inactivated vaccines (IVTBE) are used. IVTBE are safe and protect from TBE not less than 95% of vaccinated. The
Autor:
L L, Chernokhaeva, G B, Maikova, Y V, Rogova, V V, Romanenko, A V, Ankudinova, A S, Kilyachina, M F, Vorovich, G G, Karganova
Publikováno v:
Voprosy virusologii. 63(1)
The enzyme-linked immunosorbent assay (ELISA) and the neutralization test (NT) are often used to determine the level of seropositive population and to evaluate the immunogenicity of vaccines. ELISA provides information on the total pool of antiviral
Publikováno v:
Молекулярная биология. 50:353-359
Publikováno v:
Medical virology. 28:3-14
High protective efficiency of inactivated purified concentrated vaccines against tick-borne encephalitis (TBE) is proven by their long-term use in clinical practice, but the need in repeated vaccinations prompts the search for alternative vaccines. I
Publikováno v:
Molekuliarnaia biologiia. 50(2)
The interaction of viral proteins with host cell components plays an important role in antiviral immune response. One of the key steps of antiviral defense is the formation of immunoproteasomes. The effect of nonstructural protein 1 (NS1) of tick-bor